Sun Pharma Presents Phase 3 Data for WINLEVI® (clascoterone) cream 1% for the Topical Treatment of Acne Vulgaris at the AAD Annual Meeting

Sun Pharma - Milmet Labs merger Source link

FY20 Q2 Financial Result - Transcript Source link

Late-Breaking Phase 3 Data at AAD 2023 Show Oral Investigational Medicine Deuruxolitinib Significantly Improved Scalp Hair Regrowth in Alopecia Areata...

Sun Pharma completes acquisition of Concert Pharmaceuticals Source link

Sun Pharma Announces US FDA Approval for Generic Lenalidomide Capsules Source link

Sun Pharma to announce third quarter results on January 31, 2022 Source link